Background: Based on a series of clinical trials showing no difference in the effectiveness or tolerability of most major classes of antihypertensive medications, the Joint National Commission on High ...
β-blockers may increase depression risk in heart attack survivors with normal heart function, questioning their necessity for this group. The REDUCE-AMI trial found long-term β-blocker use linked to ...
Type 2 diabetes and hypertension are both insulin-resistant states that impose an excessive risk burden for future major cardiovascular events, including coronary heart disease, stroke, and heart ...
Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...
In the first report of its kind, researchers examined the combined effect of liraglutide and propranolol on the hearts of patients with both type 2 diabetes and cirrhosis. In the first study of its ...
Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results